How Would an Expert Manage His Own Chronic Myelogenous Leukemia?
When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks expert oncologist Jerald P. […]
Entries by melindaroberts
How an Expert Would Treat Her Own Metastatic Melanoma: an Update
Cancer patients often ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Stanford University School of Medicine oncologist Pauline Funchain, MD, how […]
A Better Way to Keep an Eye on Glioblastoma Tumors
For people with glioblastoma brain tumors, it can be vital yet challenging to determine the precise size, location, and extent of the tumor. A company called Imaging Biometrics, LLC, has […]
How an Expert Would Manage His Own Advanced Bladder Cancer: An Update
When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Daniel E.C. Fein, MD, […]
How an Expert Would Manage His Wife’s Metastatic Breast Cancer: An Update
For most people with breast cancer, a lump is the first sign that leads to diagnosis. But some cases are not detected until after spread has already occurred. Here, our […]
How an Expert Would Manage Her Own Advanced Colorectal Cancer: An Update
When facing a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks oncologist Christina Wu, MD, how […]
How an Expert Would Treat His Own Advanced Lung Cancer: An Update
A new cancer diagnosis is overwhelming. Patients often ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks lung cancer expert Howard (Jack) […]
How an Expert Would Manage His Own Advanced Prostate Cancer: An Update
When facing a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Marc B. Garnick, MD, how […]
The Personalized Power of the “N-of-1” Approach
Randomized, controlled clinical trials with a large N—number of participants—are the recognized “gold standard” of evidence-based medicine. Even so, the results of large-N trials can only reveal population averages, and […]
How Would an Expert Manage His Own Acute Myelogenous Leukemia: an Update
When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Previously, our Curious Dr. George asked leukemia expert Adam Asch, […]